A Consensus on Minimizing the Risk of Hyaluronic Acid Embolic Visual Loss and Suggestions for Immediate Bedside Management
| Autor: | Greg J Goodman, Ava Shamban, Peter Callan, Izolda Heydenrych, Cara B McDonald, Stefania Roberts, Steven Liew, Krishan Mohan Kapoor, Philip S Bekhor, Tatjana Pavicic, Alice Rudd, Ashish C. Bhatia, Shobhan Manoharan, Mark R. Magnusson, Sean Arendse, Michael Molton, Michael Clague, Sarah Hart, Katy Wallace, David E Kosenko, Peter Hsien-Li Peng, Niamh Corduff |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Consensus Best practice Visual impairment MEDLINE Cosmetic Techniques 030230 surgery Blindness 030207 dermatology & venereal diseases 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Dermal Fillers Intervention (counseling) Hyaluronic acid medicine Humans Hyaluronic Acid Intensive care medicine Adverse effect AcademicSubjects/MED00987 business.industry Asj/1 Original Articles General Medicine Body Contouring medicine.disease Editor's Choice Safety profile chemistry Surgery medicine.symptom business |
| Zdroj: | Aesthetic Surgery Journal |
| ISSN: | 1527-330X 1090-820X |
| Popis: | Background Hyaluronic acid fillers have a satisfactory safety profile. However, adverse reactions do occur, and rarely intravascular injection may lead to blindness. Currently there is no internationally recognized consensus on the prevention or management of blindness from hyaluronic acid filler. Objectives The authors sought to give guidance on how to minimize the risk and optimize the management of this rare but catastrophic adverse reaction. Methods A multinational group of experts in cosmetic injectables from multiple disciplines convened to review current best practice and develop updated consensus recommendations for prevention and bedside intervention if visual loss occurs after cosmetic injection of hyaluronic acid filler. Results The consensus group provided specific recommendations focusing on the consenting process, prevention, and early management of visual impairment related to intravascular hyaluronic acid filler injection. Conclusions Although visual loss due to filler injections is rare, it is important that both patient and physician be aware of this risk. In this paper the authors describe methods and techniques available to reduce the risk and also document suggested initial management should a clinician find themselves in this situation. Level of Evidence: 5 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|